Twist Bioscience Corp (TWST)
47.04
+0.54
(+1.16%)
USD |
NASDAQ |
May 17, 16:00
47.04
0.00 (0.00%)
After-Hours: 20:00
Twist Bioscience Research and Development Expense (Quarterly): 24.15M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 24.15M |
| December 31, 2023 | 23.10M |
| September 30, 2023 | 23.75M |
| June 30, 2023 | 24.53M |
| March 31, 2023 | 27.38M |
| December 31, 2022 | 31.24M |
| September 30, 2022 | 29.61M |
| June 30, 2022 | 36.84M |
| March 31, 2022 | 31.23M |
| December 31, 2021 | 22.63M |
| September 30, 2021 | 19.44M |
| June 30, 2021 | 19.84M |
| March 31, 2021 | 15.79M |
| December 31, 2020 | 14.00M |
| Date | Value |
|---|---|
| September 30, 2020 | 11.64M |
| June 30, 2020 | 10.44M |
| March 31, 2020 | 10.63M |
| December 31, 2019 | 10.30M |
| September 30, 2019 | 10.50M |
| June 30, 2019 | 9.007M |
| March 31, 2019 | 8.907M |
| December 31, 2018 | 7.273M |
| September 30, 2018 | 6.065M |
| June 30, 2018 | 5.268M |
| March 31, 2018 | 4.711M |
| December 31, 2017 | 4.303M |
| September 30, 2017 | 4.851M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
9.007M
Minimum
Jun 2019
36.84M
Maximum
Jun 2022
20.30M
Average
21.23M
Median
Research and Development Expense (Quarterly) Benchmarks
| Tandem Diabetes Care Inc | 46.24M |
| Perspective Therapeutics Inc | 7.452M |
| Xtant Medical Holdings Inc | 0.527M |
| Asensus Surgical Inc | 8.091M |
| Catheter Precision Inc | 0.037M |